YZi Labs Appoints Jane He as General Partner to Lead Biotech Investments and Incubation

Main Takeaways:

• YZi Labs welcomes Jane He as General Partner to lead biotech investments, while contributing to the company’s broader strategy across AI and Web3.
• Jane’s appointment comes as YZi Labs expands its investment focus beyond Web3 into AI and biotech following its recent rebrand.

YZi Labs today welcomed Jane He as General Partner to lead its biotech investments, while contributing to its broader strategy across AI and Web3.

With a distinguished track record in investing, Jane joined YZi Labs to contribute to its mission of making meaningful impact, driven by her passion for biotech innovation—a passion rooted in her family of doctors.

Before joining YZi Labs, Jane was an investor and Chief Operating Officer at a Hong Kong-based hedge fund, where she focused on growth-oriented investments in biotech and innovation-driven sectors. Her portfolio and research spanned cancer therapies (immunotherapy, cell therapy, ADCs), metabolic treatments (GLP-1 for obesity and Type 2 diabetes), oligonucleotide therapeutics (mRNA, siRNA, ASO), gene editing, sequencing, and medical devices. She is also actively exploring opportunities at the intersection of AI and biotech.

Jane also held leadership roles at PAAMCO Prisma, an alternative investment management firm, where she managed its investments into other funds in Asia. Jane holds an MBA from Stanford University, where she graduated as Arjay Miller Scholar.

"We are excited to welcome Jane to the YZi Labs team. She is not only a talented investor but also an entrepreneur at heart, driven to create meaningful change. As we expand our investment focus beyond Web3 into AI and biotech, we are building a team with deep domain expertise and a passion for exploring interdisciplinary innovations to drive our vision forward," said Ella Zhang, Head of YZi Labs.

“I’m honoured to step into this role at such a pivotal moment for YZi Labs. While I’ll be leading biotech investments, my focus extends across AI and Web3 as well. As a team, we remain committed to identifying and supporting founders who are building groundbreaking innovations across these sectors,” said Jane He, General Partner, YZi Labs.

Even with its broadened focus, YZi Labs remains laser-focused on the fundamentals, backing projects with the potential for long-term impact, regardless of market cycles or trends. YZi Labs is always on the lookout for exceptional founders driving transformative innovation–to work with us, apply at bit.ly/YZiLabs.

About YZi Labs

YZi Labs puts impact first—believing that meaningful returns will naturally follow. We invest in ventures at every stage, prioritizing those with solid fundamentals in Web3, AI, and biotech.

YZi Labs’ portfolio covers over 250 projects from over 25 countries across six continents. More than 65 of YZi Labs’ portfolio companies have gone through our incubation programs. For more information, follow YZi Labs on X.

Disclaimer: The information provided in this article is intended for informational purposes only and does not constitute investment advice, endorsement, analysis, or recommendations with respect to any financial instruments, investments, or issuers. This article may contain forward-looking statements which are by nature subject to risks and uncertainties. Investment in cryptocurrency and DeFi projects involves substantial risk, including the risk of complete loss. This article does not take into account the investment objectives, financial situation, or specific needs of any particular person and each individual is urged to consult their legal and financial advisors before making any investment decisions.